Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs
about
The Future of Xenotransplantation.Natural antibodies and the host immune responses to xenografts.Animal models in xenotransplantation.Allograft and xenograft acceptance under FK-506 and other immunosuppressant treatment.Drug development and testing in relation to cell migration and chimerism.Clinical intestinal transplantation: new perspectives and immunologic considerations.Baboon-to-human liver transplantationCell migration and chimerism after whole-organ transplantation: the basis of graft acceptanceNew immunosuppressive drugs: mechanistic insights and potential therapeutic advancesProspects of clinical xenotransplantation.Role of splenectomy in human liver transplantation under modern-day immunosuppression.Tacrolimus (FK 506)-dependent tolerance after liver and heart xenotransplantation: inhibition of humoral response and acceptance of donor organs.Effect of anticomplement agent K76 COOH on hamster-to-rat and guinea pig-to-rat heart xenotransplantation.The biological basis of and strategies for clinical xenotransplantationTacrolimus pretreatment attenuates preexisting xenospecific immunity and abrogates hyperacute rejection in a presensitized hamster to rat liver transplant modelHepatic transplantation at the University of Pittsburgh: new horizons and paradigms after 30 years of experience.A comparison of organ cultured fetal pancreas allo-, iso-, and xenografts (pig) in non-immunosuppressed non-obese diabetic mice.Application of modified two-cuff technique and multiglycosides tripterygium wilfordii in hamster-to-rat liver xenotransplant modelWill xenotransplantation ever be feasible?A morphological sequential study of mouse-to-rat cardiac xenografts.Destruction of endothelial cells by humoral factors obtained from recipients of xenografts.A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients.Anti-inflammatory and anticoagulant effects of transgenic expression of human thrombomodulin in mice.Hamster to rat kidney xenotransplantation. Effects of FK 506, cyclophosphamide, organ perfusion, and complement inhibition.Effect of anticomplement agent K-76 COOH in hamster-to-rat and guinea pig-to-rat xenotransplantation.Mechanisms of hamster kidney graft rejection in the rat.Combined immunosuppressive therapy with low dose FK506 and antimetabolites in rat allogeneic heart transplantation.Mizoribine as sole immunosuppressive agent in islet xenotransplantation models: a candidate immunosuppressant causing no adverse effects on islets.Isolation of mouse-to-rat cardiac xenograft-infiltrating cells by ex vivo propagation.Calcineurin inhibitor induces pain hypersensitivity by potentiating pre- and postsynaptic NMDA receptor activity in spinal cords.Role of UW solution and sodium nitroprusside in reperfusion of liver xenografts from guinea-pig to rat.The free radical scavenger S-PBN significantly prolongs DSG-mediated graft survival in experimental xenotransplantation.Xenotransplantation
P2860
Q33850125-1FCBA889-3D83-40DA-92E8-48BD19038591Q34015343-5B0C1D88-D0A3-42BC-8642-1CF1B1033392Q34075057-B11DC0E5-8D1A-4AB5-8F35-112AC101EC69Q34178489-273767A5-B62D-4B9A-B5CB-5ED7345CC382Q34197470-43EDFB86-FBF9-4119-B98C-22293FDB284AQ34201317-AFFFF01F-4B2C-438D-8501-A29B2BAC12F1Q34232574-4CA1F670-A929-4344-9339-68C926782031Q34241674-9FC1F070-8A3A-4764-854D-448B50F4331CQ34275358-845595C7-C61B-4E6A-A4F3-4CFEEC2113ECQ34291353-1B1A2B88-3F33-471C-84BE-9D87C9ED9C27Q34296200-FD8DBA88-2C0C-4B55-AE22-B324B6A76318Q34318216-9B438385-A429-4BD9-BD6B-FF3DA3006BECQ34421508-99CF6EB5-366C-42E2-A94F-6099A2C419C1Q34422862-A4B145EE-C21B-4E40-8917-A0C0A71A8B15Q34422891-261B361D-7B1E-49F6-9B2E-79EBC5C8BC15Q34498238-3E81D2FE-4940-4F7F-BE97-36034FF42B65Q35798436-C8314840-64A8-49F5-8295-E751CEF9D5E3Q36190725-D9C20326-2275-4DCA-BF76-0313B1DCC526Q37347546-B85E6625-2228-4572-B584-D49EC117F990Q40835031-F50A911B-B53A-4081-BAAE-ADB39AB869F2Q41829684-2A8C185B-8664-4016-9A28-6E08DA851B8EQ41973154-0F1CE5AE-4A2C-41B5-98F9-F1FB843C7787Q42069374-920277A8-2659-456D-810E-023E600FF863Q42115183-D725FEF6-A0DA-4B4B-A469-4330BACFA941Q42394788-858972D0-53BD-484B-81D8-F3E5D2CCA532Q42395277-7A3BFCDD-221B-413C-AC2C-1BDBA436A878Q42410921-8723CFCF-5E9F-4E8A-BBED-8C393A4D6C8AQ43849817-08E22214-3878-4B7A-856C-FF42AD39C717Q43975633-E8481F21-D0E1-44C2-8C12-1F20CB9F7D4AQ45369250-918823CA-2FCA-4752-A122-A28EA06FB8CCQ46529751-1641A568-2B95-4EF8-A038-D1D5B0F68267Q48471783-0610B3BA-BA8C-4132-827E-8980D10400A3Q56777177-8EFEF788-AFD4-4408-84F8-32F85936827D
P2860
Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs
description
1993 nî lūn-bûn
@nan
1993 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Hamster-to-rat heart and liver ...... 6 plus antiproliferative drugs
@ast
Hamster-to-rat heart and liver ...... 6 plus antiproliferative drugs
@en
Hamster-to-rat heart and liver ...... 6 plus antiproliferative drugs
@nl
type
label
Hamster-to-rat heart and liver ...... 6 plus antiproliferative drugs
@ast
Hamster-to-rat heart and liver ...... 6 plus antiproliferative drugs
@en
Hamster-to-rat heart and liver ...... 6 plus antiproliferative drugs
@nl
prefLabel
Hamster-to-rat heart and liver ...... 6 plus antiproliferative drugs
@ast
Hamster-to-rat heart and liver ...... 6 plus antiproliferative drugs
@en
Hamster-to-rat heart and liver ...... 6 plus antiproliferative drugs
@nl
P2093
P2860
P1433
P1476
Hamster-to-rat heart and liver ...... 6 plus antiproliferative drugs
@en
P2093
P2860
P304
701-7; discussion 707-8
P356
10.1097/00007890-199304000-00003
P577
1993-04-01T00:00:00Z